Proteoglycans: Key regulators of pulmonary inflammation and the innate immune response to lung infection

Anatomical Record

Volumn 293, Issue 6, 2010, Pages 968-981

  Gill, Sean ^a   Wight, Thomas N ^b   Frevert, Charles W ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

Chemokine; Cytokine; Extracellular matrix; Glycosaminoglycans; Infection; Lungs; Matrix metalloproteinases; Proteoglycan

Indexed keywords

AGGRECAN; AGRIN; BIGLYCAN; BLEOMYCIN; BREVICAN; CD11B ANTIGEN; CD14 ANTIGEN; CD18 ANTIGEN; CHONDROITIN SULFATE; DECORIN; DERMATAN SULFATE; GAMMA INTERFERON; HEPARAN SULFATE; HYALURONIC ACID; INTERLEUKIN 2; KERATAN SULFATE; LEUCINE; LIPOPOLYSACCHARIDE; LUMICAN; MATRIX METALLOPROTEINASE; NEUROCAN; PERLECAN; PROTEOGLYCAN; SYNDECAN 2; SYNDECAN 4; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VERSICAN;

ASTHMA; CELL MEMBRANE; CELL MIGRATION; CHRONIC LUNG DISEASE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LEUKOCYTE; LIVER SINUSOID; LUNG; LUNG CARCINOMA; LUNG FIBROSIS; LUNG INFECTION; LYMPHANGIOLEIOMYOMATOSIS; MACROPHAGE; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; PERITONEUM; PNEUMONIA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; STROMA CELL; T LYMPHOCYTE;

ANIMALS; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; LUNG; MYCOBACTERIUM TUBERCULOSIS; PNEUMONIA, BACTERIAL; PROTEOGLYCANS; RESPIRATORY MUCOSA;

EID: 77953167313     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.21094     Document Type: Review

References (137)

1. Adair-Kirk TL, Senior RM. 2008. Fragments of extracellular matrix as mediators of inflammation. Int J Biochem Cell Biol 40:1101-1110.
2. Akira S. 2009. Innate immunity to pathogens: diversity in receptors for microbial recognition. Immunol Rev 227:5-8.
3. Ali S, Palmer AC, Banerjee B, Fritchley SJ, Kirby JA. 2000. Examination of the function of RANTES, MIP-1alpha, and MIP-1beta following interaction with heparin-like glycosaminoglycans. J Biol Chem 275:11721-11727. (Pubitemid 30237735)
4. Allen BL, Filla MS, Rapraeger AC. 2001. Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition. J Cell Biol 155:845-858.
5. Amara A, Lorthioir O, Valenzuela A, Magerus A, Thelen M, Montes M, Virelizier JL, Delepierre M, Baleux F, Lortat-Jacob H, Arenzana- Seisdedos F. 1999. Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine. J Biol Chem 274:23916-23925. (Pubitemid 129531503)
6. Araujo BB, Dolhnikoff M, Silva LF, Elliot J, Lindeman JH, Ferreira DS, Mulder A, Gomes HA, Fernezlian SM, James A, Mauad T. 2008. Extracellular matrix components and regulators in the airway smooth muscle in asthma. Eur Respir J 32:61-69.
7. Bai KJ, Spicer AP, Mascarenhas MM, Yu L, Ochoa CD, Garg HG, Quinn DA. 2005. The role of hyaluronan synthase 3 in ventilator-induced lung injury. Am J Respir Crit Care Med 172:92-98. (Pubitemid 40923319)
8. Baker AH, Edwards DR, Murphy G. 2002. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 115:3719-3727. (Pubitemid 35203598)
9. Barbour AP, Reeder JA, Walsh MD, Fawcett J, Antalis TM, Gotley DC. 2003. Expression of the CD44v2-10 isoform confers a metastatic phenotype: importance of the heparan sulfate attachment site CD44v3. Cancer Res 63:887-892. (Pubitemid 36231993)
10. Bensadoun ES, Burke AK, Hogg JC, Roberts CR. 1996. Proteoglycan deposition in pulmonary fibrosis. Am J Respir Crit Care Med 154:1819-1828.
11. Bensadoun ES, Burke AK, Hogg JC, Roberts CR. 1997. Proteoglycans in granulomatous lung diseases. Eur Respir J 10:2731-2737.
12. Bernfield M, Götte M, Park W, Reizes O, Fitzgerald M, Lincecum J, Zako M. 1999. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68:729-777. (Pubitemid 29449208)
13. Bianco P, Fisher LW, Young MF, Termine JD, Robey PG. 1990. Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem 38:1549-1563. (Pubitemid 20346965)
14. Blackwood RA, Cantor JO, Moret J, Mandl I, Turino GM. 1983. Glycosaminoglycan synthesis in endotoxin-induced lung injury. Proc Soc Exp Biol Med 174:343-349. (Pubitemid 14218242)
15. Bode L, Eklund EA, Murch S, Freeze HH. 2005. Heparan sulfate depletion amplifies TNF-alpha-induced protein leakage in an in vitro model of protein-losing enteropathy. Am J Physiol Gastrointest Liver Physiol 288:G1015-G1023. (Pubitemid 40563145)
16. Bode L, Salvestrini C, Park PW, Li JP, Esko JD, Yamaguchi Y, Murch S, Freeze HH. 2008. Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function. J Clin Invest 118:229-238.
17. Bollyky PL, Falk BA,Wu RP, Buckner JH,Wight TN, Nepom GT. 2009. Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory Tcells. J Leukoc Biol 86:567-572.
18. Borghesi LA, Yamashita Y, Kincade PW. 1999. Heparan sulfate proteoglycans mediate interleukin-7-dependent B lymphopoiesis. Blood 93:140-148. (Pubitemid 29019397)
19. Bosman FT, Stamenkovic I. 2003. Functional structure and composition of the extracellular matrix. J Pathol 200:423-428. (Pubitemid 36818243)
20. Brew K, Dinakarpandian D, Nagase H. 2000. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477:267-283. (Pubitemid 30119906)
21. Brule S, Charnaux N, Sutton A, Ledoux D, Chaigneau T, Saffar L, Gattegno L. 2006. The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase- 9. Glycobiology 16:488-501.
22. Burns AR, Smith CW, Walker DC. 2003. Unique structural features that influence neutrophil emigration into the lung. Physiol Rev 83:309-336.
23. Clarke D, Katoh O, Gibbs RV, Griffiths SD, Gordon MY. 1995. Interaction of interleukin 7 (IL-7) with glycosaminoglycans and its biological relevance. Cytokine 7:325-330.
24. Coombe DR. 2008. Biological implications of glycosaminoglycan interactions with haemopoietic cytokines. Immunol Cell Biol 86:598-607.
25. David G, Lories V, Decock B, Marynen P, Cassiman JJ, Van den Berghe H. 1990. Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts. J Cell Biol 111:3165-3176.
26. Day AJ, de la Motte CA. 2005. Hyaluronan cross-linking: a protective mechanism in inflammation? Trends Immunol 26:637-643.
27. de la Motte C, Nigro J, Vasanji A, Rho H, Kessler S, Bandyopadhyay S, Danese S, Fiocchi C, Stern R. 2009. Platelet-derived hyaluronidase 2 cleaves hyaluronan into fragments that trigger monocyte-mediated production of proinflammatory cytokines. Am J Pathol 174:2254-2264.
28. de la Motte CA, Hascall VC, Drazba J, Bandyopadhyay SK, Strong SA. 2003. Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid: polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function. Am J Pathol 163:121-133.
29. de Medeiros Matsushita M, da Silva LF, dos Santos MA, Fernezlian S, Schrumpf JA, Roughley P, Hiemstra PS, Saldiva PH, Mauad T, Dolhnikoff M. 2005. Airway proteoglycans are differentially altered in fatal asthma. J Pathol 207:102-110.
30. Dolhnikoff M, Morin J, Roughley PJ, Ludwig MS. 1998. Expression of lumican in human lungs. Am J Respir Cell Mol Biol 19: 582-587.
31. Ellyard JI, Simson L, Bezos A, Johnston K, Freeman C, Parish CR. 2007. Eotaxin selectively binds heparin. An interaction that protects eotaxin from proteolysis and potentiates chemotactic activity in vivo. J Biol Chem 282:15238-15247.
32. Esko JD, Selleck SB. 2002. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 71:435-471.
33. Faggian J, Fosang AJ, Zieba M, Wallace MJ, Hooper SB. 2007. Changes in versican and chondroitin sulfate proteoglycans during structural development of the lung. Am J Physiol Regul Integr Comp Physiol 293:R784-R792.
34. Fernandez-Botran R, Yan J, Justus DE. 1999. Binding of interferon gamma by glycosaminoglycans: a strategy for localization and/or inhibition of its activity. Cytokine 11:313-325.
35. Frevert C, Wight TN. 2006. Matrix proteoglycans. In: Laurent GJ, editor. The encyclopedia of respiratory medicine. London, UK: Elsevier. p 184-187.
36. Frevert CW, Goodman RB, Kinsella MG, Kajikawa O, Ballman K, Clark-Lewis I, Proudfoot AE, Wells TN, Martin TR. 2002. Tissue-specific mechanisms control the retention of IL-8 in lungs and skin. J Immunol 168:3550-3556.
37. Frevert CW, Kinsella MG, Vathanaprida C, Goodman RB, Baskin DG, Proudfoot A, Wells TN, Wight TN, Martin TR. 2003. Binding of interleukin-8 to heparan sulfate and chondroitin sulfate in lung tissue. Am J Respir Cell Mol Biol 28:464-472. (Pubitemid 36399368)
38. Frevert CW, Sannes PL. 2006. Matrix proteoglycans as effector molecules for epithelial cell function. Eur Respir Rev 14:137-144.
39. Gospodarowicz D, Cheng J. 1986. Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 128:475-484. (Pubitemid 16015532)
40. Gotte M. 2003. Syndecans in inflammation. FASEB J 17:575-591.
41. Groffen AJ, Buskens CA, van Kuppevelt TH, Veerkamp JH, Monnens LA, van den Heuvel LP. 1998. Primary structure and high expression of human agrin in basement membranes of adult lung and kidney. Eur J Biochem 254:123-128.
42. Halfter W, Dong S, Schurer B, Cole GJ. 1998. Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J Biol Chem 273:25404-25412. (Pubitemid 28443308)
43. Hasan M, Najjam S, Gordon MY, Gibbs RV, Rider CC. 1999. IL-12 is a heparin-binding cytokine. J Immunol 162:1064-1070.
44. Hashimoto G, Aoki T, Nakamura H, Tanzawa K, Okada Y. 2001. Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4). FEBS Lett 494:192-195.
45. Hirose J, Kawashima H, Yoshie O, Tashiro K, Miyasaka M. 2001. Versican interacts with chemokines and modulates cellular responses. J Biol Chem 276:5228-5234. (Pubitemid 37371420)
46. Hoebe K, Janssen E, Beutler B. 2004. The interface between innate and adaptive immunity. Nat Immunol 5:971-974.
47. Huang J, Olivenstein R, Taha R, Hamid Q, Ludwig M. 1999. Enhanced proteoglycan deposition in the airway wall of atopic asthmatics. Am J Respir Crit Care Med 160:725-729. (Pubitemid 29380696)
48. Hurt-Camejo E, Rosengren B, Sartipy P, Elfsberg K, Camejo G, Svensson L. 1999. CD44, a cell surface chondroitin sulfate proteoglycan, mediates binding of interferon-gamma and some of its biological effects on human vascular smooth muscle cells. J Biol Chem 274:18957-18964. (Pubitemid 129519313)
49. Iida J, Wilhelmson KL, Ng J, Lee P, Morrison C, Tam E, Overall CM, McCarthy JB. 2007. Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A). Biochem J 403:553-563. (Pubitemid 46706984)
50. Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, Prestwich GD, Mascarenhas MM, Garg HG, Quinn DA, Homer RJ, Goldstein DR, Bucala R, Lee PJ, Medzhitov R, Noble PW. 2005. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 11:1173-1179. (Pubitemid 43093664)
51. Johnson GB, Brunn GJ, Platt JL. 2004. Cutting edge: an endogenous pathway to Systemic Inflammatory Response Syndrome (SIRS)-like reactions through Toll-like receptor 4. J Immunol 172:20-24.
52. Karlinsky JB. 1982. Glycosaminoglycans in emphysematous and fibrotic hamster lungs. Am Rev Respir Dis 125:85-88.
53. Kashiwagi M, Tortorella M, Nagase H, Brew K. 2001. TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J Biol Chem 276:12501-12504. (Pubitemid 37385157)
54. Kassim SY, Gharib SA, Mecham BH, Birkland TP, Parks WC, McGuire JK. 2007. Individual matrix metalloproteinases control distinct transcriptional responses in airway epithelial cells infected with Pseudomonas aeruginosa. Infect Immun 75:5640-5650.
55. Kawashima H, Watanabe N, Hirose M, Sun X, Atarashi K, Kimura T, Shikata K, Matsuda M, Ogawa D, Heljasvaara R, Rehn M, Pihlajaniemi T, Miyasaka M. 2003. Collagen XVIII, a basement membrane heparan sulfate proteoglycan, interacts with L-selectin and monocyte chemoattractant protein-1. J Biol Chem 278:13069-13076. (Pubitemid 36800075)
56. Keck RG, Berleau L, Harris R, Keyt BA. 1997. Disulfide structure of the heparin binding domain in vascular endothelial growth factor: characterization of posttranslational modifications in VEGF. Arch Biochem Biophys 344:103-113. (Pubitemid 27328102)
57. Kenagy RD, Plaas AH, Wight TN. 2006. Versican degradation and vascular disease. Trends Cardiovasc Med 16:209-215.
58. Kim CW, Goldberger OA, Gallo RL, Bernfield M. 1994. Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. Mol Biol Cell 5:797-805. (Pubitemid 24254349)
59. Kim S, Takahashi H, Lin WW, Descargues P, Grivennikov S, Kim Y, Luo JL, Karin M. 2009. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457: 102-106.
60. Kinsella MG, Bressler SL, Wight TN. 2004. The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype. Crit Rev Eukaryot Gene Expr 14:203-234.
61. Koopmann W, Ediriwickrema C, Krangel MS. 1999. Structure and function of the glycosaminoglycan binding site of chemokine macrophage- inflammatory protein-1 beta. J Immunol 163:2120-2127. (Pubitemid 29382218)
62. Koslowski R, Pfeil U, Fehrenbach H, Kasper M, Skutelsky E, Wenzel KW. 2001. Changes in xylosyltransferase activity and in proteoglycan deposition in bleomycin-induced lung injury in rat. Eur Respir J 18:347-356. (Pubitemid 32776412)
63. Kuschert GS, Coulin F, Power CA, Proudfoot AE, Hubbard RE, Hoogewerf AJ, Wells TN. 1999. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38:12959-12968. (Pubitemid 29463294)
64. Kuschert GS, Hoogewerf AJ, Proudfoot AE, Chung CW, Cooke RM, Hubbard RE, Wells TN, Sanderson PN. 1998. Identification of a glycosaminoglycan binding surface on human interleukin-8. Biochemistry 37:11193-11201. (Pubitemid 28394867)
65. Lau EK, Paavola CD, Johnson Z, Gaudry J-P, Geretti E, Borlat F, Kungl AJ, Proudfoot AE, Handel TM. 2004. Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1; implications for structure and function in vivo. J Biol Chem 279:22294-22305. (Pubitemid 38679426)
66. Lee S, Bowrin K, Hamad AR, Chakravarti S. 2009. Extracellular matrix lumican deposited on the surface of neutrophils promotes migration by binding to {beta}2 integrin. J Biol Chem 284:23662-23669.
67. Li Q, Park PW, Wilson CL, Parks WC. 2002. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111:635-646. (Pubitemid 35441246)
68. Lipscombe RJ, Nakhoul AM, Sanderson CJ, Coombe DR. 1998. Interleukin-5 binds to heparin/heparan sulfate. A model for an interaction with extracellular matrix. J Leukoc Biol 63:342-350.
69. Lories V, Cassiman JJ, Van den Berghe H, David G. 1992. Differential expression of cell surface heparan sulfate proteoglycans in human mammary epithelial cells and lung fibroblasts. J Biol Chem 267:1116-1122.
70. Lortat-Jacob H. 2006. Interferon and heparan sulphate. Biochem Soc Trans 34:461-464.
71. Lortat-Jacob H, Baltzer F, Grimaud JA. 1996. Heparin decreases the blood clearance of interferon-gamma and increases its activity by limiting the processing of its carboxyl-terminal sequence. J Biol Chem 271:16139-16143. (Pubitemid 26236230)
72. Lortat-Jacob H, Garrone P, Banchereau J, Grimaud JA. 1997. Human interleukin 4 is a glycosaminoglycan-binding protein. Cytokine 9:101-105.
73. Lowry MH, McAllister BP, Jean JC, Brown LA, Hughey RP, Cruikshank WW, Amar S, Lucey EC, Braun K, Johnson P, Wight TN, Joyce-Brady M. 2008. Lung lining fluid glutathione attenuates IL-13-induced asthma. Am J Respir Cell Mol Biol 38:509-516. (Pubitemid 351758668)
74. Luster AD, Greenberg SM, Leder P. 1995. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med 182:219-231.
75. Lyon M, Rushton G, Gallagher JT. 1997. The interaction of the transforming growth factor-betas with heparin/heparan sulfate is isoform-specific. J Biol Chem 272:18000-18006. (Pubitemid 27306378)
76. McCawley LJ, Matrisian LM. 2001. Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol 13: 534-540.
77. McDonald B, McAvoy EF, Lam F, Gill V, de la Motte C, Savani RC, Kubes P. 2008. Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids. J Exp Med 205:915-927. (Pubitemid 351549887)
78. McQuibban GA, Butler GS, Gong JH, Bendall L, Power C, Clark- Lewis I, Overall CM. 2001. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 276:43503-43508. (Pubitemid 37383907)
79. McQuibban GA, Gong JH, Wong JP, Wallace JL, Clark-Lewis I, Overall CM. 2002. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100:1160-1167. (Pubitemid 34864266)
80. Merrilees MJ, Ching PS, Beaumont B, Hinek A, Wight TN, Black PN. 2008. Changes in elastin, elastin binding protein and versican in alveoli in chronic obstructive pulmonary disease. Respir Res 9:41.
81. Merrilees MJ, Hankin EJ, Black JL, Beaumont B. 2004. Matrix proteoglycans and remodelling of interstitial lung tissue in lymphangioleiomyomatosis. J Pathol 203:653-660. (Pubitemid 38714102)
82. Miller JD, Stevens ET, Smith DR, Wight TN, Wrenshall LE. 2007. Perlecan: a major IL-2-binding proteoglycan in murine spleen. Immunol Cell Biol 86:192-199.
83. Mizgerd JP. 2008. Acute lower respiratory tract infection. N Engl J Med 358:716-727.
84. Mongiat M, Sweeney SM, San Antonio JD, Fu J, Iozzo RV. 2003. Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J Biol Chem 278:4238-4249. (Pubitemid 36801161)
85. Mulloy B, Rider CC. 2006. Cytokines and proteoglycans: an introductory overview. Biochem Soc Trans 34:409-413.
86. Murdoch AD, Liu B, Schwarting R, Tuan RS, Iozzo RV. 1994. Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J Histochem Cytochem 42:239-249. (Pubitemid 24042241)
87. Noble PW, Jiang D. 2006. Matrix regulation of lung injury, inflammation, and repair: the role of innate immunity. Proc Am Thorac Soc 3:401-404. (Pubitemid 44033352)
88. Page-McCaw A, Ewald AJ, Werb Z. 2007. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8:221-233. (Pubitemid 46310551)
89. Parish CR. 2006. The role of heparan sulphate in inflammation. Nat Rev Immunol 6:633-643.
90. Parks WC, Wilson CL, Lopez-Boado YS. 2004. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 4:617-629. (Pubitemid 39025047)
91. Perkins GD, Nathani N, Richter AG, Park D, Shyamsundar M, Heljasvaara R, Pihlajaniemi T, Manji M, Tunnicliffe W, McAuley D, Gao F, Thickett DR. 2009. Type XVIII collagen degradation products in acute lung injury. Crit Care 13:R52.
92. Petersen F, Bock L, Flad HD, Brandt E. 1998. A chondroitin sulfate proteoglycan on human neutrophils specifically binds platelet factor 4 and is involved in cell activation. J Immunol 161:4347-4355. (Pubitemid 28469020)
93. Porter S, Clark IM, Kevorkian L, Edwards DR. 2005. The ADAMTS metalloproteinases. Biochem J 386:15-27.
94. Potter-Perigo S, Johnson PY, Evanko SP, Chan CK, Braun KR, Wilkinson TS, Altman LC, Wight TN. 2009. Poly I:C stimulates versican accumulation in the extracellular matrix promoting monocyte adhesion. Am J Respir Cell Mol Biol. In Press.
95. Proudfoot AEI, Handel TM, Johnson Z, Lau EK, LiWang P, Clark- Lewis I, Borlat F, Wells TNC, Kosco-Vilbois MH. 2003. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. PNAS 100:1885-1890. (Pubitemid 36254543)
96. Ra HJ, Parks WC. 2007. Control of matrix metalloproteinase catalytic activity. Matrix Biol 26:587-596.
97. Ramsden L, Rider CC. 1992. Selective and differential binding of interleukin (IL)-1 alpha, IL-1 beta, IL-2 and IL-6 to glycosaminoglycans. Eur J Immunol 22:3027-3031.
98. Rapraeger AC. 2002. Heparan sulfate-growth factor interactions. Methods Cell Biol 69:83-109.
99. Rosengart TK, Kuperschmid JP, Maciag T, Clark RE. 1989. Pharmacokinetics and distribution of heparin-binding growth factor I (endothelial cell growth factor) in the rat. Circ Res 64:227-234. (Pubitemid 19054019)
100. Rot A. 1992. Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol Today 13:291-294.
101. Sadir R, Imberty A, Baleux F, Lortat-Jacob H. 2004. Heparan sulfate/ heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. J Biol Chem 279:43854-43860.
102. Salek-Ardakani S, Arrand JR, Shaw D, Mackett M. 2000. Heparin and heparan sulfate bind interleukin-10 and modulate its activity. Blood 96:1879-1888.
103. Sampson PM, Boyd RB, Pietra GG, Fishman AP. 1984. Glycosaminoglycan biosynthesis in the isolated perfused rat lung. J Appl Physiol 57:1648-1654.
104. Sandy JD, Westling J, Kenagy RD, Iruela-Arispe ML, Verscharen C, Rodriguez-Mazaneque JC, Zimmermann DR, Lemire JM, Fischer JW, Wight TN, Clowes AW. 2001. Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J Biol Chem 276:13372-13378.
105. Sannes PL. 1984. Differences in basement membrane-associated microdomains of type I and type II pneumocytes in the rat and rabbit lung. J Histochem Cytochem 32:827-833.
106. Sannes PL, Khosla J, Cheng PW. 1996. Sulfation of extracellular matrices modifies responses of alveolar type II cells to fibroblast growth factors. Am J Physiol 271:L688-L697.
107. Sannes PL, Khosla J, Li CM, Pagan I. 1998. Sulfation of extracellular matrices modifies growth factor effects on type II cells on laminin substrata. Am J Physiol 275:L701-L708.
108. Schaefer L, Babelova A, Kiss E, Hausser HJ, Baliova M, Krzyzankova M, Marsche G, Young MF, Mihalik D, Gotte M, Malle E, Schaefer RM, Grone HJ. 2005. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest 115:2223-2233.
109. Schaefer L, Iozzo RV. 2008. Biological functions of the small leucine- rich proteoglycans: from genetics to signal transduction. J Biol Chem 283:21305-21309.
110. Schor H, Vaday GG, Lider O. 2000. Modulation of leukocyte behavior by an inflamed extracellular matrix. Dev Immunol 7:227-238.
111. Smits NC, Robbesom AA, Versteeg EM, Van De Westerlo EM, Dekhuijzen PN, Van Kuppevelt TH. 2004. Heterogeneity of heparan sulfates in human lung. Am J Respir Cell Mol Biol 30:166-173.
112. Sorensen HP, Vives RR, Manetopoulos C, Albrechtsen R, Lydolph MC, Jacobsen J, Couchman JR, Wewer UM. 2008. Heparan sulfate regulates ADAM12 through a molecular switch mechanism. J Biol Chem 283:31920-31932.
113. Spillmann D, Witt D, Lindahl U. 1998. Defining the interleukin-8- binding domain of heparan sulfate. J Biol Chem 273:15487-15493.
114. Taylor KR, Gallo RL. 2006. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J 20:9-22.
115. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL. 2004. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 279:17079-17084.
116. Taylor KR, Yamasaki K, Radek KA, Di Nardo A, Goodarzi H, Golenbock D, Beutler B, Gallo RL. 2007. Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J Biol Chem 282:18265-18275.
117. Tester AM, Cox JH, Connor AR, Starr AE, Dean RA, Puente XS, Lopez-Otin C, Overall CM. 2007. LPS responsiveness and neutrophil chemotaxis in vivo require PMN MMP-8 activity. PLoS One 2:e312.
118. Vaday GG, Franitza S, Schor H, Hecht I, Brill A, Cahalon L, Hershkoviz R, Lider O. 2001. Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix. J Leukoc Biol 69:885-892.
119. Vaday GG, Lider O. 2000. Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inflammation. J Leukoc Biol 67:149-159.
120. Van den Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G. 2000. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 96:2673-2681.
121. Van Den Steen PE, Wuyts A, Husson SJ, Proost P, Van Damme J, Opdenakker G. 2003. Gelatinase B/MMP-9 and neutrophil collagenase/ MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. Eur J Biochem 270:3739-3749.
122. Venkatesan N, Ebihara T, Roughley PJ, Ludwig MS. 2000. Alterations in large and small proteoglycans in bleomycin-induced pulmonary fibrosis in rats. Am J Respir Crit Care Med 161:2066-2073.
123. Venkatesan N, Roughley PJ, Ludwig MS. 2002. Proteoglycan expression in bleomycin lung fibroblasts: role of transforming growth factor-beta(1) and interferon-gamma. Am J Physiol Lung Cell Mol Physiol 283:L806-L814.
124. Wang L, Brown JR, Varki A, Esko JD. 2002. Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. J Clin Invest 110:127-136.
125. Webb LM, Ehrengruber MU, Clark LI, Baggiolini M, Rot A. 1993. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc Natl Acad Sci USA 90:7158-7162.
126. Wettreich A, Sebollela A, Carvalho MA, Azevedo SP, Borojevic R, Ferreira ST, Coelho-Sampaio T. 1999. Acidic pH modulates the interaction between human granulocyte- macrophage colony-stimulating factor and glycosaminoglycans. J Biol Chem 274:31468-31475. (Pubitemid 129501602)
127. Wight TN. 2008. Arterial remodeling in vascular disease: a key role for hyaluronan and versican. Front Biosci 13:4933-4937.
128. Wight TN, Heinegard DK, Hascall VC. 1991. Proteoglycans: structure and function. In: Hay E, editor. Cell biology of the extracellular matrix. 2nd ed. New York: Plenum Press. p 45-77.
129. Wrenshall LE, Platt JL. 1999. Regulation of T cell homeostasis by heparan sulfate-bound IL-2. J Immunol 163:3793-3800.
130. Wrenshall LE, Platt JL, Stevens ET, Wight TN, Miller JD. 2003. Propagation and control of T cell responses by heparan sulfate-bound IL-2. J Immunol 170:5470-5474.
131. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433. (Pubitemid 20341908)
132. Wu F, Vij N, Roberts L, Lopez-Briones S, Joyce S, Chakravarti S. 2007. A novel role of the lumican core protein in bacterial lipopolysaccharide- induced innate immune response. J Biol Chem 282:26409-26417. (Pubitemid 47443780)
133. Yu WH, Yu S, Meng Q, Brew K, Woessner JF, Jr. 2000. TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J Biol Chem 275:31226-31232.
134. Zatterstrom UK, Felbor U, Fukai N, Olsen BR. 2000. Collagen XVIII/endostatin structure and functional role in angiogenesis. Cell Struct Funct 25:97-101. (Pubitemid 30453806)
135. Zen K, Liu DQ, Li LM, Chen CX, Guo YL, Ha B, Chen X, Zhang CY, Liu Y. 2009. The heparan sulfate proteoglycan form of epithelial CD44v3 serves as a CD11b/CD18 counter-receptor during polymorphonuclear leukocyte transepithelial migration. J Biol Chem 284:3768-3776.
136. Zhang K, McQuibban GA, Silva C, Butler GS, Johnston JB, Holden J, Clark-Lewis I, Overall CM, Power C. 2003. HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor- 1 causes neurodegeneration. Nat Neurosci 6:1064-1071. (Pubitemid 37186198)
137. Zheng PS, Vais D, Lapierre D, Liang YY, Lee V, Yang BL, Yang BB. 2004. PG-M/versican binds to P-selectin glycoprotein ligand-1 and mediates leukocyte aggregation. J Cell Sci 117:5887-5895. (Pubitemid 40123954)